Announced Wed, 8 Apr · 13:14 IST

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter and year ended on 31st March, 2026 received from M/s. Bigshare Services Pvt. ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.3%1-day move

₹52.80

prior close

₹54.00

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0+0.0-0.2+0.3+1.3-2.3+0.9-0.2-2.5-4.3-5.0+0.4-7.2

Up moveDown movePending

AI summary

Eiko Lifesciences Ltd submitted a routine compliance certificate for Q4 and full year ended March 31, 2026. The certificate, issued by Bigshare Services Pvt. Ltd. (the company's Registrar and Share Transfer Agent), confirms that no dematerialisation requests for equity shares were received during the period January 1, 2026 to March 31, 2026. This is a standard regulatory filing required under SEBI regulations. The company has a CIN of L65993MH1977PLC258134 and is listed on BSE with scrip code 540204.

Likely market impact

This is a routine, non-event filing confirming zero demat activity during the quarter. It has no direct impact on the stock price or shareholder value — it simply demonstrates normal operational compliance.